Guidance
Update information
December 2021: Following a surveillance review we have updated recommendations 1.6.5 and 1.6.6 to say that either glycosylated haemoglobin (HbA1c) or fasting blood glucose may be used to test for diabetes in people taking antipsychotic medication. These recommendations last had an evidence review in 2013, and we updated them without an evidence review in 2021. The recommendations are marked [2013, amended 2021].
April 2017: Four research recommendations were identified as out of date in a 2017 surveillance review, and have been deleted.
Minor changes since publication
May 2024: We have simplified the guideline by removing recommendations on general principles of care that are covered in other NICE guidelines (for example, the NICE guideline on service user experience in adult mental health). This is a presentational change only, and no changes to practice are intended.
ISBN: 978-1-4731-0055-8